Indrayani Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

45.54

45.54

34.23

34.23

34.23

Share application money

-

-

-

-

-

Preference share capital

-

-

9.25

-

-

Reserves & surplus

9.80

8.98

7.67

-10.05

-14.28

Loan funds

Secured loans

61.66

58.60

35.27

9.95

7.28

Unsecured loans

-

-

-

6.79

8.15

Total

116.99

113.11

86.42

40.91

35.38

Uses of funds

Fixed assets

Gross block

20.53

25.80

23.81

15.33

15.11

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

3.87

4.14

-

-

-

Net block

16.66

21.66

23.81

15.33

15.11

Capital work-in-progress

18.09

18.03

12.72

13.22

13.72

Investments

9.61

9.56

7.99

0.19

0.19

Net current assets

Current assets, loans & advances

86.31

76.76

55.79

20.70

10.83

Less : current liabilities & provisions

13.69

12.90

13.88

8.53

4.47

Total net current assets

72.63

63.87

41.91

12.18

6.37

Miscellaneous expenses not written

-

-

-

-

-

Total

116.99

113.11

86.42

40.91

35.38

Notes:

Book value of unquoted investments

0.61

9.56

7.99

0.19

-

Market value of quoted investments

18.12

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

455.36

455.36

342.27

342.27

342.27